Intratumoral delivery of tavokinogene telseplasmid yields systemic immune responses in metastatic melanoma patients
Algazi, A., Bhatia, S., Agarwala, S., Molina, M., Lewis, K., Faries, M., Fong, L., Levine, L.P., Franco, M., Oglesby, A., Ballesteros-Merino, C., Bifulco, C.B., Fox, B.A., Bannavong, D., Talia, R., Browning, E., Le, M.H., Pierce, R.H., Gargosky, S., Tsai, K.K., Twitty, C., Daud, A.I.
Published in Annals of oncology (01.04.2020)
Published in Annals of oncology (01.04.2020)
Get full text
Journal Article
Abstract P2-09-11: Intratumoral tavokinogene telseplasmid and electroporation in pre-treated inoperable locally advanced or recurrent triple-negative breast cancer
Telli, ML, Zablotsky, K, Le, MH, Canton, D, Browning, E, Bannavong, D, Gargosky, S, Wapnir, I
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Get full text
Journal Article